Targeting key proximal drivers of type 2 inflammation in disease
The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Abstract
Systemic type 2 inflammation encompassing T helper 2 (TH2)-type responses is emerging as a unifying feature of both classically defined allergic diseases, such as asthma, and a range of other inflammatory diseases. Rather than reducing inflammation with broad-acting immunosuppressants or narrowly targeting downstream products of the TH2 pathway, such as immunoglobulin E (IgE), efforts to target the key proximal type 2 cytokines - interleukin-4 (IL-4), IL-5 and IL-13 - represent a promising strategy to achieve therapeutic benefit across multiple diseases. After several initial disappointing clinical results with therapies targeting IL-4, IL-5 or IL-13 in asthma, applying a personalized approach achieved therapeutic benefit in an asthma subtype exhibiting an 'allergic' phenotype. More recently, efficacy was extended into a broad population of people with asthma. This argues that the Type 2 inflammation is broadly relevant across the severe asthma population if the key upstream drivers are properly blocked. Moreover, the simultaneous inhibition of IL-4 and IL-13 has shown significant clinical activity in diseases that are often co-morbid with asthma - atopic dermatitis and chronic sinusitis with nasal polyps - supporting the hypothesis that targeting a central 'driver pathway' could benefit multiple allergic diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lebrikizumab does not affect the binding of IL-13 to the IL-13Rα2 receptor chain, the biological role of which remains unclear81.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [81]
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Asher, M. I., Montefort, S., Björkstén, B., Lai, C. K., Strachan, D. P., Weiland, S. K., & Williams, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69283-0 · Cited by 4,223
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Development and validation of a questionnaire to measure asthma control
Juniper, E. F., O′byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d29.x · Cited by 2,473
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., Cohen, N., Cervin, A., Douglas, R., Gevaert, P., et al. (2012) · Rhinology journal · doi:10.4193/rhino12.000 · Cited by 2,387
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,273
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Research works printed but not linked: 5
- Pawankar, R., Canonica, G., Holgate, S. & Lockey, R. WAO White Book on Allergy 2011–2012: Executive Summary (World Allergy Organization, 2011).
- Wenzel, S. E. et al. Inhaled pitrakinra, an IL-4/IL-13 antagonist, reduced exacerbations in patients with eosinophilic asthma. Eur. Respir. J. 36 (Suppl. 54), 713s (2010).
- Wenzel, S. et al. Dupilumab improves lung function and reduces severe exacerbations in uncontrolled asthmatics with baseline eosinophil levels above and below 300 cells/μl. Am. J. Respir. Crit. Care Med. 191, A3632 (2015).
- Kaiser, J. Medical Officer's Efficacy Review, Genentech, Omalizumab BLA STN 103976/0. US Food and Drug Administration [online] , (2003).
- Groves, R., Wilbrahams, D., Fuller, R. & Longphre, M. Inhibition of IL-4 and IL-13 with an IL-4 mutein (Aeroderm) protects against flares in atopic eczema. J. Invest. Dermatol. 127 (Suppl. 1s), S54 (2007).
Cited by
Items 601–700 of 800
Zhang, L., Davis, J. D., Kanamaluru, V., & Xu, C. R. (2025) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70057 · Cited by 1
Lu, A. J., Morris, S., & Weissmann, L. B. (2025) · Cureus · doi:10.7759/cureus.87724 · Cited by 1
Desrosiers, M. Y., Nash, S., Lane, A., Lee, S. E., Corso, E. D., Xia, C., Corbett, M., Radwan, A., Rowe, P. J., & Deniz, Y. M. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03378-2 · Cited by 2
Purdy, K. S., Gooderham, M., Abu‐Hilal, M., Armstrong, A. W., Asiniwasis, R. N., Dhadwal, G., Jack, C. S., Lansang, P., Lovegrove, F. E., Ringuet, J., et al. (2025) · JAAD International · doi:10.1016/j.jdin.2025.06.009 · Cited by 1
The role of type 2 inflammation in the pathogenesis of atopic dermatitis
Elisyutina, O. G., Smolnikov, E. V., Chernushevich, D. D., Litovkina, A. O., Byazrova, M. G., Левкова, Е. А., & Fedenko, E. S. (2025) · RUDN Journal of Medicine · doi:10.22363/2313-0245-2025-29-3-365-384 · Cited by 1
Baek, J., Choi, D. H.-S., Park, B. E., Cho, E., Kim, K., Lee, J.-Y., Shin, J. W., & Kim, W. (2026) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2511.11044 · Cited by 2
Zhi Chuan Ling oral liquid alleviates Th2-type asthma via IL-4–JAK1–STAT6 and KIT signaling pathways
Yang, J., Xl, Z., Weng, D.-Z., Wang, H., Jin, Z., Han, J.-Y., Liu, J., & Feng, C. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121408 · Cited by 1
Lommatzsch, M., Schmidt, O., Timmermann, H., Gappa, M., Watz, H., Kwah, J. H., Ledanois, O., Nischan, N., Hahn, M., Heimann, A., et al. (2026) · Respiratory Medicine · doi:10.1016/j.rmed.2026.108750 · Cited by 1
Li, Y., Li, H., Zhang, Q., Cui, S., Zhai, Q., Stanton, C., Ross, P. M., Zhao, J., Chen, W., & Yang, B. (2026) · Food & Function · doi:10.1039/d5fo05688h · Cited by 1
Chase, N. M. (2026) · Allergy and Asthma Proceedings · doi:10.2500/aap.2026.47.260001 · Cited by 1
Design of binder proteins specific to IL-13
Hu, Y., Weng, J., Chen, Y., Xing, B., Xiang, H., Zhao, W., & Wei, Z. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151813 · Cited by 1
Yan, P., Chen, L., Ming, G., Chen, Z., Gou, Q., Yuan, Y., Jing, H., Luo, P., Zhang, J., & Zhao, Z. (2026) · Vaccines · doi:10.3390/vaccines14040347 · Cited by 1
Furci, F., Scaramozzino, M. U., Furci, A., Chello, C., Parisella, F. R., Pelaia, C., Caruso, C., & Tammaro, A. (2026) · Biologics · doi:10.3390/biologics6020013 · Cited by 1
Zhao, Y., Liu, Y., Cai, S., Zhang, N., Wu, S., Shi, Y., Ma, Y., Liu, S., He, Y., Wang, Q., et al. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107339 · Cited by 1
Busse, W. W., Castro, M., Lugogo, N. L., O’Byrne, P. M., Bacharier, L. B., Xia, C., Ledanois, O., & Soliman, M. (2026) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2026.05.019 · Cited by 1
Factors Associated With Dupilumab Efficacy in Patients With Chronic Rhinosinusitis With Nasal Polyps
Takaishi, S., & Otori, N. (2026) · OTO Open · doi:10.1002/oto2.70241 · Cited by 1
Influence of fungi on epithelial homeostasis and role in inflammatory diseases
Peterson, L. F., Wang, J., Gow, N. A. R., LeibundGut‐Landmann, S., & Brewer, M. G. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00319-25 · Cited by 1
Immunomodulatory effects of nematode-microbiota interactions in cancer therapy
Oksenych, V., Rashidan, M., Khazaei, M., & Tahmasebi, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1803276 · Cited by 1
Han, J., Lim, D.-W., Kwon, O., Lee, Y. J., Choi, M., Lee, B., Noh, S., Cho, M., & Lee, Y.-M. (2026) · Nutrients · doi:10.3390/nu18142382 · Cited by 2
Schmidt, E., Ferrer, M., Kim, B., & Simpson, E. L. (2026) · American Journal of Clinical Dermatology · doi:10.1007/s40257-026-01052-z · Cited by 1
Alotaibi, M. A., Alhelal, S. M., Alotaibi, N., & Alsudairy, F. (2026) · Case Reports in Dermatological Medicine · doi:10.1155/crdm/8570980 · Cited by 1
Antiphlogistika und Antiallergika
Offermanns, S. (2016) · Springer-Lehrbuch · doi:10.1007/978-3-662-46689-6_24 · Cited by 1
Santos, A., Barbosa, A., Taminato, A., Malbouisson, I., & Laredo, F. (2021) · Jornal Brasileiro de Economia da Saúde · doi:10.21115/jbes.v13.n3.p279-87 · Cited by 1
Poliposis nasosinusal. Rinosinusitis crónica con pólipos
Bonfils, P., Halimi, P., Gaultier, A.-L., & Lisan, Q. (2017) · EMC - Otorrinolaringología · doi:10.1016/s1632-3475(17)85515-6 · Cited by 1
Velter, C. (2018) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2018.06.003 · Cited by 1
Mechanisms and Practical Use of Biologic Therapies for Allergy and Asthma Indications
Damask, C. C., & Franzese, C. B. (2021) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2021.04.003 · Cited by 1
Marrón, S. E., Tomas-Aragones, L., Moncin-Torres, C. A., Gómez-Barrera, M., & de Aranibar, F. J. G.-L. (2021) · Life · doi:10.3390/life11070617 · Cited by 1
中丸, 裕. (2021) · Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo) · doi:10.3950/jibiinkotokeibu.124.12_1555 · Cited by 1
New possibilities of therapy of T2-associated diseases
Hutueva, S. H., Shogenova, M. S., Alieva, I. Z., & Shogenova, L. S. (2021) · Consilium Medicum · doi:10.26442/20751753.2021.8.201183 · Cited by 1
Editorial Board (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.08.201050 · Cited by 1
Holgate, S. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-80912-2.00007-x · Cited by 1
Antiphlogistika und Antiallergika
Offermanns, S. (2020) · Springer eBooks · doi:10.1007/978-3-662-58304-3_24 · Cited by 1
New Frontiers in Chronic Obstructive Pulmonary Disease: Where Are We Heading?
Agustí, A. G. N., Christenson, S. A., Han, M. K., & Singh, D. (2022) · EMJ Respiratory · doi:10.33590/emjrespir/10038710 · Cited by 1
Dupilumab zur Behandlung von Genodermatosen: Eine systematische Übersicht
Wu, P., Dai, Y., Li, C., Chen, C., Chang, Y.-T., & Ma, S. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14924_g · Cited by 1
Treatment of asthma and eosinophilic allergic diseases using biological products
Kim, S. (2023) · Journal of Korean Medical Association · doi:10.5124/jkma.2023.66.9.523 · Cited by 1
Li, Q., Li, Y., Wu, F., Li, J., Li, Z., Qin, X., Wei, S., & Chen, C. (2023) · Cell Adhesion & Migration · doi:10.1080/19336918.2023.2265158 · Cited by 1
Wasnik, U., Lakade, S. H., Harde, M. T., Banduke, M., Dighe, T., More, A. V., Nale, P., Patange, A., Waghmare, S., & Kharsade, D. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00690 · Cited by 1
Ayurvedic management of vicharchika - A case report
Keerthi, P. V., & P.M.Madhu (2023) · Kerala Journal of Ayurveda · doi:10.55718/kja.198 · Cited by 1
First Case of Superficial Epidermolytic Ichthyosis Successfully Treated by Dupilumab
Wang, C., Pan, C., Dou, J., Zhang, S., Song, J., Li, M., & Wang, J. (2024) · Dermatitis · doi:10.1089/derm.2023.0334 · Cited by 1
Allergic Disposition of IVF-Conceived Mice
Ahmadi, H., Bognár, Z., Csabai, T. J., Obodo, B. N., & Szekeres‐Barthó, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312993 · Cited by 1
Nitric Oxide Donor Metallodrug: Single-Inhaler Proposal for Rescue in Acute Allergic Asthma Crises
Costa, P. P. C., Waller, S. B., Ramos, H. H., Lopes-Neto, B. E., & Ribeiro, W. L. C. (2025) · Biology · doi:10.3390/biology14030244 · Cited by 1
Transcriptome analysis of Aeromonas hydrophila infected Channel catfish (Ictalurus punctatus)
Li, X., Chen, F., Kong, J., Shang, B., Li, Z., Du, Q., Zhang, X., & Shen, X. (2025) · International Conference on Bioinformatics and Intelligent Computing (BIC) · doi:10.1145/3724979.3725027 · Cited by 1
Koryagin, F. N., Георгиевна, П. Т., & Nagornev, S. N. (2025) · Fizioterapevt (Physiotherapist) · doi:10.33920/med-14-2503-09 · Cited by 1
Epigenetic Regulation of Peripheral Macrophages in Neuropathic Pain
Kiguchi, N., Matsuzaki, S., Saika, F., Kobayashi, D., & Kishioka, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814070-3.00002-8 · Cited by 1
[Advances in the endotypes of chronic rhinosinusitis].
Jiang, Z., & Meng, J. (2020) · PubMed Central · doi:10.13201/j.issn.1001-1781.2020.01.004 · Cited by 1
Mesiakaris, K., Atsopardi, Κ., Margarity, M., & Poulas, K. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.19.440455 · Cited by 1
Defining Type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysisPreprint
Canonica, G. W., Blasi, F., Crimi, N., Paggiaro, P., Papi, A. A., Fanelli, F., Stassaldi, A., & Furneri, G. (2020) · doi:10.21203/rs.3.rs-44856/v1 · Cited by 1
Benedetto, A. D. (2024) · Dermatitis · doi:10.1089/derm.2023.0423 · Cited by 1
The Differentiation and Function of Th2 and Th9 Cells
Gros, G. S. L., & Kyle, R. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.08003-6
Snapshots of CD4+ T cell plasticity in the pathogenesis of allergic asthma
Chae, W., & Bothwell, A. L. M. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.08.19
Roberts, G. C., Boyle, R., Bryce, P. J., Crane, J., Hogan, S. P., Saglani, S., Wickman, M. C., & Woodfolk, J. A. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12823
Périostine et maladies inflammatoires bronchiques
Dinh‐Xuan, A. T. (2016) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(16)30099-4
Protein Therapeutics in Respiratory Medicine
Shrimanker, R., & Pavord, I. D. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527699124.ch17
Poliposi nasosinusale. Rinosinusite cronica con polipi
Bonfils, P., Halimi, P., Gaultier, A.-L., & Lisan, Q. (2017) · EMC - Otorinolaringoiatria · doi:10.1016/s1639-870x(17)86064-5
Characterisation of the immune cells and cytokines involved in a model of atopic dermatitis
Naidoo, K. (2018) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17067641.v1
Cancérologie cutanée et dermatite atopique
Petit, A., Lenormand, C., & Velter, C. (2019) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(19)30102-4
Atopic Dermatitis: From Physiopathology to the Clinics
Figueras‐Nart, I., & Palomares, Ó. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89108 · Cited by 2
Brief Immunology Review for Targeted Biologic Therapies in Allergic Disease
Franzese, C. B. (2020) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-020-00263-0
The Role of Thromboxane A2 in Bronchial Asthma
张, 子. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.112073
Aplinkos veiksnių įtaka astmai bei kitoms alerginėms ligoms pasireikšti
Vaidelienė, L., & Vaidelys, L. (2020) · Pulmonology and allergology · doi:10.37499/pia.142
Bakker, D. S. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/905
Efeitos do dupilumabe na neurofibromatose tipo 1 concomitante com dermatite atópica grave
Chello, C., Sernicola, A., Paolino, G., & Grieco, T. (2021) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abdp.2021.07.016
Palačionytė, J., & Malakauskas, K. (2021) · Pulmonology and allergology · doi:10.37499/pia.761
Epigenetics and precision medicine in allergic diseases
Tost, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823008-4.00019-6
Parametric processes in a cavity resonator terminated with a DC-SQUID
Nguyen, F., Zakka-Bajjani, E., Lee, M., Spietz, L., Vale, L. R., Simmonds, R. W., & Aumentado, J. (2011) · Bulletin of the American Physical Society
Generation and Gene Expression of CD28−CD8 T Cells in Human
Kim, J., & Weng, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_17
Generation and Gene Expression of CD28−CD8 T Cells in Human
Kim, J., & Weng, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_17-1
Typ-2-Erkrankungen interdisziplinär behandeln
(2021) · hautnah · doi:10.1007/s12326-021-00444-8
Dermatoses inflammatoires et auto-immunes
Lenormand, C., Kluger, N., & Velter, C. (2022) · Annales de Dermatologie et de Vénéréologie - FMC · doi:10.1016/s2667-0623(22)00107-6 · Cited by 1
Dermatite atopique et psoriasis
Lenormand, C., Kluger, N., & Velter, C. (2022) · Annales de Dermatologie et de Vénéréologie - FMC · doi:10.1016/s2667-0623(22)00108-8
Penn, R. B. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727436785.793546220
The TGF-β-Th2 axis: a new target for cancer therapy?Preprint
de Durango, C. G., Escribese, M. M., & Rosace, D. (2021) · doi:10.22541/au.161700446.65128539/v1
Galli, E., Pedone, M. P., Dobreva, M., Bitonti, R., & Turi, R. D. (2022) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v23i1.1527
Dong, X., & Zhong, N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101004
Pathogenetic connection of chronic sinusitis with polyps and new coronavirus infection
Tovmasyan, A. S., Ramazanov, S. R., Mosin, V. V., Klimenko, K. E., Filina, E. V., & Bolgar, A. Y. (2022) · Russian Rhinology · doi:10.17116/rosrino202230031192
Coavoy-Sánchez, S. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2021.tde-05112021-180853
Dupilumab: para além da dermatite atópica
Rodrigues, R., Abreu, C., & Silva, R. F. (2022) · Revista Portuguesa de Imunoalergologia · doi:10.32932/rpia.2022.12.095
Translating Evidence to Practice: From Clinical Research to Real-World Experience
Mayor, S. (2019) · EMJ Dermatology · doi:10.33590/emjdermatol/10313810
Stutfield, S. (2018) · EMJ Allergy & Immunology · doi:10.33590/emjallergyimmunol/10310787
Discovering Asthma Paradigms in an Evolving Landscape: Expert Perspectives
Scutt, P. (2018) · EMJ Respiratory · doi:10.33590/emjrespir/10311221
Modern Approaches to the Treatment of Chronic Polypous Rhinosinusitis
Валерьевна, Б. Е., Сухарева, Ю. В., & Galeev, R. F. (2023) · Оториноларингология Восточная Европа · doi:10.34883/pi.2023.13.2.029
Exploring Type 2 Inflammation in Chronic Obstructive Pulmonary Disease
Liao, D. (2023) · EMJ Respiratory · doi:10.33590/emjrespir/10306588
The development of a method to target pathological collagen remodeling in asthma
Jamieson, R. (2023) · Digital Repository Service (Northeastern University) · doi:10.17760/d20581980
Biologic drugs, a new therapeutic paradigm in moderate-severe atopic dermatitis
Vignoli, C. A., & Borroni, R. G. (2023) · doi:10.37349/eaa.2023.00020
CADTH (2023) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2023.798
Dupilumab in the treatment of severe adopic dermatitis and respiratory allergy: a case report
Афонина, И. А., & Shkodkina, S. A. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-477
Ou, G., Qing, L., Zhang, L., Yang, Y., Ye, G., Peng, L., Li, Y., Yang, L., & Liu, Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1332666
Wann Biologika bei schwerem Asthma besonders effektiv sind
Gillissen, A. (2024) · Pneumo News · doi:10.1007/s15033-023-3955-9
Atopic March; The Skin is the Clue
Attia, E. A. S. (2024) · Journal of dermatology and clinical research. · doi:10.47739/2373-9371.dermatology.1157
Pharmacologic Treatment of Type 2-High Severe Asthma
Bosi, A., Simeone, M. S., Ghinassi, F., Baroncini, S., Ruggieri, V., & Beghé, B. (2024) · Medical Research Archives · doi:10.18103/mra.v12i4.5029
Викторович, Ф. А. (2024) · Russian Bulletin of Otorhinolaryngology · doi:10.17116/otorino20248902195
Study the impact of the Interlukines and Vit.E in patients with Atopic Eczema in Anbar Governorate
Abdullah, H., Mohammed, W. Y., & Hasan, A. A. (2024) · Journal of university of Anbar for pure science · doi:10.37652/juaps.2023.144631.1165
Unravelling the Complexities and Recent Advances in the Management of Atopic Dermatitis
Pandey, V. P., Punniyamoorthy, S., Pradhan, S., Umar, M., Bano, U., Pokharel, Y. R., Karwasra, R., Umar, T., & Kumar, P. (2024) · Current Drug Therapy · doi:10.2174/0115748855299561240802111649
Levina, J. G., Александровна, П. П., Геннадьевна, К. В., Efendieva, K. E., Vishneva, Е. A., Alekseeva, A. A., & Namazova-Baranova, L. S. (2024) · Педиатрическая фармакология · doi:10.15690/pf.v21i4.2788
Metadata
- Authors
- Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D.
- Affiliations
- Regeneron (United States) (US)
- Sanofi (United States) (US)
- Corresponding author
- Gandhi, Namita A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-10-16
- Volume
- 15
- Issue
- 1
- Pages
- 35-50
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2200308911
- Cited by
- 766
- References
- 156
- Citations by year
- 2026: 70 · 2025: 104 · 2024: 113 · 2023: 77 · 2022: 106 · 2021: 99 · 2020: 63 · 2019: 43 · 2018: 33 · 2017: 38 · 2016: 18
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Regeneron Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- type 2 inflammation, IL-4, IL-5, IL-13, asthma, atopic dermatitis, Th2 cells, allergic diseases, IL-4 receptor alpha inhibition, IL-13 inhibition, IL-5 inhibition, personalized asthma therapy, drug candidates
- MeSH terms
- Antibodies, Monoclonal, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Interleukin-4, Interleukin-5, Models, Immunological, Interleukin-13, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.